United Kingdom - English - VMD (Veterinary Medicines Directorate)

msd animal health uk limited - canine parvovirus - powder for suspension for injection - live viral vaccine - dogs

United Kingdom - English - VMD (Veterinary Medicines Directorate)

zoetis uk limited - canine coronovirus, canine distemper virus, canine parvovirus - lyophilisate for suspension for injection - live and inactivated viral vaccine - dogs

Ireland - English - HPRA (Health Products Regulatory Authority)

intervet ireland limited - canine parvovirus attenuated strain 154 - lyophilisate and solvent for suspension for injection - . - canine parvovirus - dogs - immunological - live vaccine

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

plasvacc pty ltd - canine erythrocytes - unknown - canine erythrocytes blood product active 0.0 - active constituent

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - bordetella bronchiseptica (inactivated cell free extract; canine distemper virus - living; canine parainfluenza virus; canine adenovirus type 2 live (cav ii); canine parvo virus type 2 - parenteral liquid/solution/suspension - bordetella bronchiseptica (inactivated cell free extract vaccine-microbial active 0.0 qs dose; canine distemper virus - living vaccine-viral active 0.0 qs dose; canine parainfluenza virus vaccine-viral active 0.0 qs dose; canine adenovirus type 2 live (cav ii) vaccine-viral active 0.0 qs dose; canine parvo virus type 2 vaccine-viral active 0.0 qs dose - immunotherapy - dog | bitch | castrate | puppy - bordetella bronchiseptica | canine distemper | canine parvovirus | hepatitis :- infectious | parainfluenza virus type 2 (infections) | canine adenovirus type 1 | canine adenovirus type 2 | canine cough syndrome | infections caused by parainflu | infectious canine hepatitis | infectious tracheobronchitis | parvovirus

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - canine distemper virus, strain cdv bio 11/a, canine adenovirus type 2, strain cav-2 bio 13, canine parvovirus type 2b, strain cpv-2b bio 12/b and canine parainfluenza type 2 virus, strain cpiv-2 bio 15 (all live attenuated) - immunologicals for canidae, live viral vaccines - dogs - active immunisation of dogs from six weeks of age.to prevent mortality and clinical signs caused by canine distemper virus,to prevent mortality and clinical signs caused by canine adenovirus type 1,to prevent clinical signs and reduce viral excretion caused by canine adenovirus type 2,to prevent clinical signs, leukopenia and viral excretion caused by canine parvovirus,to prevent clinical signs and reduce viral excretion caused by canine parainfluenza virus.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - canine parainfluenza type 2; gentamicin - misc. vaccines or anti sera - canine parainfluenza type 2 vaccine-viral active 0.0 tci50/do; gentamicin antibiotic other 0.0 p - immunotherapy - dog | dog - over 6 weeks old | bitch | castrate | puppy - canine parainfluenza

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

plasvacc pty ltd - canine gamma globulins; trisodium citrate - parenteral liquid/solution/suspension - canine gamma globulins vaccine active 10.0 g/l; trisodium citrate ungrouped other 4.0 g/l - immunotherapy - dog | bitch | castrate | puppy - aid in combating infection | coagulopathies | disseminated intravascular coagulation | hypoproteinaemia | pancreatitis | parvovirus enteritis | coumarin poisoning | indanedione poisoning | post-injury | post-surgery | sweet clover (dicoumarol) pois | warfarin poisoning

Ireland - English - HPRA (Health Products Regulatory Authority)

virbac s.a. - leptospria interrogans serogroup icterohaemorragiae, inactivated, leptospira interrogans serogroup canicoia, inactivated - suspension for injection - 80/80 % - leptospira vaccine - canine - immunological - inactivated vaccine

European Union - English - EMA (European Medicines Agency)

zoetis belgium s.a. - leptospira interrogans serogroup australis serovar bratislava, strain mslb 1088, l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae, strain mslb 1089, l. interrogans serogroup canicola serovar canicola, strain mslb 1090, l. kirschneri serogroup grippotyphosa serovar grippotyphosa, strain mslb 1091 (all inactivated) - inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia), immunologicals for canidae - dogs - active immunisation of dogs from six weeks of age to prevent clinical signs, infection and urinary excretion caused by leptospira serovars bratislava, canicola, grippotyphosa and icterohaemorrhagiae. onset of immunity: immunity has been demonstrated from 4 weeks after completion of the primary course. duration of immunity: at least one year following the primary vaccination course.